San Diego-based Viking Therapeutics marked by itself as a serious competitor from the weight loss drug marketplace in February following revealing promising knowledge from the mid-stage demo of experimental drug VK2735, which instructed it rivaled—and outperformed—Novo and Lilly drugs when supplied as being a weekly injection As well as in Marc